BayWa’s Rescue Plan Fractures as Trump-Era Bill Kills €1.7 Billion Windfall, Triggers €2.7 Billion Gap

US wind and solar subsidy cuts derail BayWa's €1.7bn renewable sale, leaving €2.7bn gap. Creditors face €1bn write-off, legal probes mount.

The restructuring blueprint for BayWa has collapsed under the weight of a single US legislative decision. The “One Big Beautiful Bill Act,” signed into law by Donald Trump, slashed subsidies for wind and solar projects, rendering the planned sale of a majority stake in the renewable energy arm BayWa r.e. unviable. That deal had been the cornerstone of the Münich-based agricultural group’s debt-reduction strategy, with an expected €1.7 billion in proceeds now gone.

Without that injection, a vast hole has opened in the company’s finances. The total shortfall is put at €2.7 billion, according to an updated internal assessment. To bridge the gap, management is now pushing for a brutal resolution: creditors must waive approximately €1 billion of their claims. A new rescue concept is due by mid-2026, but negotiations are already turning acrimonious as lenders and shareholders square off over who bears the heaviest burden.

Nowhere is the tension sharper than among the cooperative banks. The Volks- und Raiffeisenbanken are BayWa’s largest shareholders and also its lenders, a double exposure that has already left deep marks on their balance sheets. In their 2024 financial statements, they wrote down 60% of a €220 million Schuldschein loan. Verbandspräsident Stefan Müller has not ruled out a total loss on that instrument. Meanwhile, the larger commercial lenders – DZ Bank and UniCredit – are demanding a full debt haircut, subordination agreements, and a prolonged dividend freeze. The cooperatives’ own shareholder interests clash directly with those demands, slowing progress.

Ancillary asset sales are doing little to close the gap. The management has mandated Goldman Sachs since March 2026 to find a buyer for T&G Global, the New Zealand apple-subsidiary behind brands such as Envy and Jazz. T&G generated $1.3 billion in revenue in 2024, and the expected sale price is around €300 million. Yet the minority shareholder, Hong Kong-based Joy Wing Mau Group, is dragging its feet. Even if the deal goes through, it will cover only a fraction of the missing billions. Of the €4 billion in total divestments the group had targeted, BayWa has secured €1.3 billion so far.

The legal front is also heating up. Germany’s financial watchdog BaFin formally reprimanded the company for omitting essential details in its 2023 management report – specifically a €1 billion credit facility and risks tied to a €500 million bond. The law firm TILP has used the reprimand to file damage claims on behalf of shareholders who bought stock between early 2022 and early 2026. Separately, the Munich public prosecutor’s office is investigating former chief executives on suspicion of breach of trust and false accounting. All accused benefit from the presumption of innocence. The audit regulator Apas is also preparing proceedings against PwC, which gave the 2023 accounts an unqualified audit opinion.

Investors have voted with their feet. BayWa’s stock slid to €13.10 on Wednesday, down 8.4% over the past week and 21.8% since the start of the year. The bearish mood reflects the combination of a broken asset sale, mounting legal risk, and an uncertain timetable for a fresh financing deal.

On 26 May, the board will publish its first-quarter trading update, shifting the focus back to liquidity and cost-cutting. By autumn, the critical talks with DZ Bank and UniCredit on extending the existing standstill agreement will determine whether the restructuring plan can hold. If that conversation fails, the entire legal basis for the turnaround crumbles. BayWa aims to shrink to four core business lines by 2028, cutting around 1,300 jobs along the way, but without a binding accord with its bankers, the path forward remains precarious.